Sernova (SVA) Competitors C$0.24 0.00 (0.00%) (As of 01:31 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider Trades SVA vs. ABCN, EMC, FRX, BCT, IPA, MDNA, ONC, COV, SCYB, and COMShould you be buying Sernova stock or one of its competitors? The main competitors of Sernova include VIVO Cannabis (ABCN), Emblem (EMC), Fennec Pharmaceuticals (FRX), BriaCell Therapeutics (BCT), ImmunoPrecise Antibodies (IPA), Medicenna Therapeutics (MDNA), Oncolytics Biotech (ONC), Covalon Technologies (COV), Scythian Biosciences (SCYB), and 138267 (COM.TO) (COM). These companies are all part of the "biotechnology" industry. Sernova vs. VIVO Cannabis Emblem Fennec Pharmaceuticals BriaCell Therapeutics ImmunoPrecise Antibodies Medicenna Therapeutics Oncolytics Biotech Covalon Technologies Scythian Biosciences 138267 (COM.TO) VIVO Cannabis (CVE:ABCN) and Sernova (TSE:SVA) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, community ranking, valuation, profitability, dividends, media sentiment, risk and earnings. Do analysts recommend ABCN or SVA? Sernova has a consensus target price of C$1.83, suggesting a potential upside of 663.89%. Given Sernova's stronger consensus rating and higher possible upside, analysts clearly believe Sernova is more favorable than VIVO Cannabis.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score VIVO Cannabis 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Sernova 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.00 Does the media refer more to ABCN or SVA? In the previous week, VIVO Cannabis' average media sentiment score of 0.00 equaled Sernova'saverage media sentiment score. Company Overall Sentiment VIVO Cannabis Neutral Sernova Neutral Is ABCN or SVA more profitable? VIVO Cannabis' return on equity of 0.00% beat Sernova's return on equity.Company Net Margins Return on Equity Return on Assets VIVO CannabisN/A N/A N/A Sernova N/A -726.29%-119.26% Do institutionals and insiders believe in ABCN or SVA? 0.1% of Sernova shares are owned by institutional investors. 12.1% of Sernova shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Does the MarketBeat Community prefer ABCN or SVA? VIVO Cannabis received 117 more outperform votes than Sernova when rated by MarketBeat users. However, 91.67% of users gave Sernova an outperform vote while only 71.91% of users gave VIVO Cannabis an outperform vote. CompanyUnderperformOutperformVIVO CannabisOutperform Votes12871.91% Underperform Votes5028.09% SernovaOutperform Votes1191.67% Underperform Votes18.33% Which has stronger valuation & earnings, ABCN or SVA? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVIVO CannabisN/AN/AN/AN/AN/ASernovaN/AN/A-C$38.93M-C$0.13-1.85 SummarySernova beats VIVO Cannabis on 7 of the 10 factors compared between the two stocks. Ad Darwin2025 AI Stock Picks: 2 Hidden Gems Under $10/ShareThe AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] Get Sernova News Delivered to You Automatically Sign up to receive the latest news and ratings for SVA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SVA vs. The Competition Export to ExcelMetricSernovaBiotechnology IndustryMedical SectorTSE ExchangeMarket CapC$78.08MC$163.46MC$5.09BC$6.19BDividend Yield7.86%3.50%5.04%5.31%P/E Ratio-1.85329.4794.6026.60Price / SalesN/A14,863.411,217.521,474.09Price / Cash6.1511.6739.4982.35Price / Book-6.007.056.953.13Net Income-C$38.93M-C$18.37MC$118.83MC$292.70M7 Day Performance4.35%0.19%-1.52%1.32%1 Month Performance-5.88%8.18%-3.39%13.16%1 Year Performance-65.71%25.03%32.17%44.29% Sernova Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SVASernovaN/AC$0.24flatC$1.83+663.9%-66.7%C$78.08MN/A-1.851,959Gap DownABCNVIVO CannabisN/AC$1.32+5.6%N/A+0.0%C$256.62MN/A0.00N/AGap UpEMCEmblemN/A$1.88+1.6%N/A+0.0%$245.45M$5.71M-9.89N/AFRXFennec PharmaceuticalsN/AC$6.82+4.9%N/A-42.5%C$186.60MC$48.89M64.7010Analyst UpgradeNews CoverageGap UpBCTBriaCell TherapeuticsN/AC$10.60-3.8%C$15.00+41.5%+0.0%C$168.68MN/A-28.195IPAImmunoPrecise AntibodiesN/AC$6.50+0.8%N/A+0.0%C$162.08MC$19.47M-7.3080Gap DownMDNAMedicenna TherapeuticsN/AC$1.50flatN/A+252.9%C$114.65MN/A-3.9520Gap UpONCOncolytics Biotech1.4019 of 5 starsC$1.38-1.4%C$3.50+153.6%-34.6%C$106.07MN/A-3.6829Analyst RevisionCOVCovalon TechnologiesN/AC$3.83-1.8%N/A+271.4%C$104.94MC$29.20M-97.50N/ASCYBScythian BiosciencesN/AC$3.49-5.9%N/A+0.0%C$102.38MN/A0.00N/AHigh Trading VolumeCOM138267 (COM.TO)N/AN/AN/A+0.0%C$102.19MN/A0.00N/A Related Companies and Tools Related Companies VIVO Cannabis Alternatives Emblem Alternatives Fennec Pharmaceuticals Alternatives BriaCell Therapeutics Alternatives ImmunoPrecise Antibodies Alternatives Medicenna Therapeutics Alternatives Oncolytics Biotech Alternatives Covalon Technologies Alternatives Scythian Biosciences Alternatives 138267 (COM.TO) Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (TSE:SVA) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sernova Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sernova With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
